Basic Cyklokapron Information

• INN (International Nonproprietary Name): Tranexamic acid.
• Brand Names Available In United States: Lysteda (oral formulation marketed in the USA) and generic tranexamic acid tablets; injectable brands such as Cyklokapron and Exacyl are listed in other countries.
• ATC Code: B02AA02.
• Forms & Dosages: Tablets commonly 500 mg (also 250 mg); injection at 100 mg/mL supplied in ampoules (5/10 mL) or vials (10 mL); oral solution (100 mg/mL) is rare.
• Manufacturers In United States: Major global suppliers include Pfizer, Sanofi, Mylan/Viatris, Zentiva, Polpharma, Arrow and other generics manufacturers as listed in product data.
• Registration Status In United States: Tranexamic acid is widely registered; the oral brand Lysteda is marketed in the USA and injectable product information notes FDA oversight for IV use.
• OTC / Rx Classification: Prescription only (Rx) in the listed countries, including the United States.

Instructions, Warnings & Daily-Life Integration

Morning Vs Evening Dosing

Which is better, morning or evening dosing?

Routine oral courses for heavy menstrual bleeding normally use tranexamic acid tablets taken two to three times a day rather than a single once-daily dose.

Typical adult dosing for menorrhagia is 1,000–1,300 mg up to three times daily for up to five days, so spacing doses across waking hours is standard.

Choose morning, midday and evening slots that fit your routine to keep steady levels and improve adherence.

If your prescriber orders IV tranexamic acid, timing depends on the procedure and provider instructions rather than a simple morning/evening choice.

Taking With Or Without Meals

Does food change how well tranexamic acid works?

There are no major food interactions reported for tranexamic acid tablets.

Taking the tablet with food can reduce nausea and help with tolerance if you develop gastrointestinal upset.

If a rapid effect is needed per prescriber instruction, follow those timing directions even if that means taking it on an empty stomach.

For IV use, food timing is not relevant; follow your clinician’s perioperative protocol.

Practical instructions first: Cyklokapron (tranexamic acid) is prescription-only and commonly comes as 500 mg tablets or 100 mg/mL injection.

For routine oral courses, for example heavy menstrual bleeding, typical adult dosing is 1,000–1,300 mg up to three times daily for up to five days — follow your prescriber’s exact plan.

Take missed doses as soon as you remember unless it’s near the next dose; never double up doses to make up missed medicine.

For IV use, dosing and timing depend on the procedure and provider orders and are established by anesthesia or surgical teams.

Safety warnings up front: do not use tranexamic acid if you have active blood clots, a history of seizures, or a known allergy to tranexamic acid.

If you use combined hormonal contraception, mention this to your clinician because clot risk is a relative concern to weigh against bleeding benefit.

In renal impairment, dose adjustments are required because tranexamic acid is primarily renally cleared; discuss dosing with your prescriber if you have kidney disease.

Daily-life integration tips:

• Schedule doses with routine activities such as after brushing teeth, with breakfast, with lunch, and with dinner to improve adherence.
• If nausea occurs, take tablets with a light snack or meal unless otherwise directed by your prescriber.
• Prefer a daily dosing checklist: morning dose, midday dose, evening dose, and record when taken.

Red-Flag Symptoms — Seek Urgent Care:

• New unilateral leg swelling or pain.
• Sudden shortness of breath or chest pain.
• New severe or persistent headache or visual disturbance.
• Seizure activity or unexplained loss of consciousness.

Safety Priorities

Who Should Avoid It

Who must not take tranexamic acid?

Avoid tranexamic acid with active intravascular clotting such as deep vein thrombosis or pulmonary embolism; this is an absolute contraindication.

Do not use tranexamic acid if you have a history of convulsions or seizures; seizures are a documented serious adverse effect.

Known hypersensitivity to tranexamic acid is an absolute contraindication.

Discuss with specialists if you have a history of thromboembolic events or are receiving clotting-factor concentrates, as these are relative contraindications that require individualized assessment.

Renal impairment requires dose reductions because tranexamic acid is mainly renally eliminated; severe renal dysfunction (e.g., creatinine clearance <30 mL/min) needs careful adjustment.

Activities To Limit

What activities should be limited while taking tranexamic acid?

Avoid prolonged immobilization without appropriate thromboprophylaxis when you have clot risk, such as long flights or extended bed rest.

Follow your surgical team’s advice about returning to high-risk sports after procedures; avoid strenuous activity if advised to reduce bleeding risk.

If you experience visual disturbances, new severe headache, unilateral swelling, or chest pain, stop the medication and seek urgent evaluation because these signs can indicate thrombosis or rare severe effects.

Dosage & Adjustments

General Regimen

What dosing schedules are typical?

For heavy menstrual bleeding, standard oral dosing in adults is 1,000–1,300 mg taken up to three times daily for up to five days per cycle.

For bleeding prophylaxis around dental work or surgery, common regimens use 1,000–1,500 mg orally or intravenously two to three times daily, often started before or during the event and continued for up to seven to eight days according to the procedure.

Pediatric dosing is weight-based at about 10–15 mg/kg per dose given two to three times daily, adjusted for renal function and specialist guidance.

Maximum daily limits vary by indication and institutional protocol, so always confirm the prescriber’s exact plan.

Special Cases

How do clinicians adjust dosing for special situations?

Renal impairment requires dose reduction or increased dosing intervals when creatinine clearance is low, particularly below 30 mL/min.

Elderly patients commonly need no routine adjustment unless renal function is reduced.

For IV perioperative use, follow institutional protocols or anesthesiologist guidance; product information lists IV concentration at 100 mg/mL in ampoules or vials.

If combined with clotting-factor concentrates, disseminated intravascular coagulation, or in other complex coagulation disorders, consult a hematologist or specialist before using tranexamic acid.

User Testimonials

Positive Reports

What do patients say when tranexamic acid works well?

Many patients report quick and meaningful reductions in heavy menstrual bleeding after starting tranexamic acid tablets, often noticing less flooding and fewer soaked pads within one to two cycles.

Patients who received tranexamic acid for dental procedures or minor surgery commonly report reduced postoperative oozing and easier packing removal or stitches management.

Short testimonial quote: "My period was much lighter the first month I tried tranexamic acid tablets, and I felt more confident going out.".

Common Challenges

What problems do people commonly experience?

Common challenges include gastrointestinal upset such as nausea or diarrhea, headaches, and muscle or back pain; these are typically mild to moderate.

Some users report difficulty remembering a two- or three-times-daily schedule, which can reduce effectiveness.

Rare but serious events such as seizures or thrombotic complications are infrequent, but when reported in forums they are described as alarming; any such signs require immediate medical review.

• Positive: faster bleeding control for heavy periods, less postoperative oozing.
• Challenges: nausea, headaches, dosing schedule adherence, rare serious events.

Checklist: contact your clinician if you have new leg swelling, shortness of breath, sudden vision change, severe headache, or any seizure activity.

Buying Guide

Pharmacy Sources

Where can you get tranexamic acid or Cyklokapron?

Tranexamic acid is prescription-only in most countries and is supplied by major manufacturers including Pfizer, Sanofi, Mylan/Viatris and many generics manufacturers.

In the United States, the oral brand Lysteda is marketed for menorrhagia, while injectable ampoules or vials for IV use are stocked by hospitals and infusion pharmacies.

Our online pharmacy carries cyklokapron and offers discreet delivery to United States in 5-14 days for eligible orders.

Price Comparison

How to shop wisely for the lowest cost.

Compare prices between chain and independent pharmacies and ask about generic tranexamic acid as a lower-cost option.

Check manufacturer discount cards for branded products and ask your pharmacist about pack-size pricing differences between 30-tablet and 100-tablet packs.

Bring to the pharmacy: valid prescription, insurance card, photo ID, and any coupon or manufacturer discount information.

What’s Inside & How It Works

Ingredients Overview

What is the active ingredient?

The active ingredient is tranexamic acid, usually formulated as 500 mg tablets or a 100 mg/mL injectable solution.

Excipients vary by manufacturer, so check the package leaflet if you have allergies to fillers or dyes.

Common brands include Cyklokapron and Exacyl internationally and Lysteda for oral use in the United States.

Mechanism Basics

How does tranexamic acid stop bleeding?

Tranexamic acid is an antifibrinolytic that helps blood clots remain intact by blocking fibrinolysis.

At a biochemical level, TXA competitively inhibits activation of plasminogen to plasmin, reducing plasmin-mediated fibrin degradation.

Clinically, that means less oozing from mucosal surfaces such as the uterus or oral cavity and reduced bleeding during and after procedures.

Check excipients on the package leaflet if you have known allergies to tablets' inactive ingredients.

Main Indications

Approved Uses

What is tranexamic acid officially used for?

Common approved indications include heavy menstrual bleeding (menorrhagia) and bleeding prophylaxis in surgery or dental procedures, especially for patients with bleeding disorders.

IV tranexamic acid is used for surgical and trauma-related bleeding in clinical settings and is supplied as 100 mg/mL ampoules or vials.

In many countries brands such as Cyklokapron and Exacyl are licensed for these uses, and in the US oral Lysteda is an available option for menorrhagia.

Off-Label Uses

Where else is tranexamic acid used under clinician direction?

Off-label or institutional uses include treatment for epistaxis with topical or oral administration, some protocols for hereditary angioedema in certain regions, and trauma-related hemorrhage protocols.

Off-label use should always be clinician-directed because dosing and monitoring differ from standard menorrhagia regimens.

Interaction Warnings

Food Interactions

Are there any food interactions to be aware of?

There are no major food interactions reported for tranexamic acid tablets.

Taking tablets with food can reduce nausea and improve tolerance if gastrointestinal upset occurs.

Maintain hydration, especially if you have clot risk or are travelling long distances.

Drug Conflicts

Which drugs can interact with tranexamic acid?

A key concern is combining tranexamic acid with prothrombotic agents or when using clotting-factor concentrates; specialist input is recommended in such cases.

Concomitant use with aminocaproic acid is generally redundant and not recommended due to similar mechanisms.

Tranexamic acid does not reverse anticoagulation; inform clinicians if you are taking anticoagulants, because combined management requires specialist consideration.

Also flag drugs that increase seizure risk; seizures are a rare but serious adverse effect of tranexamic acid and may be more likely when combined with other proconvulsant agents.

Latest Evidence & Insights

Key Trials Summary

What does the evidence say about tranexamic acid?

Randomized trials support tranexamic acid’s efficacy in reducing bleeding in heavy menstrual bleeding and various surgical settings.

Evidence shows reduced transfusion requirements in many surgical procedures when tranexamic acid is used appropriately.

Early administration in trauma has been associated with mortality benefit in selected contexts in large trials and guideline recommendations.

Practical Takeaways

How should patients interpret the evidence?

Tranexamic acid is effective when used as directed and is typically prescribed for short courses for menorrhagia or perioperative bleeding control.

Benefits are greatest when the medication is started promptly in acute bleeding or according to perioperative timing protocols.

Because serious risks like thrombosis and seizures are rare but important, a full medical history is essential before starting therapy.

• Evidence-based Indications: Menorrhagia and perioperative bleeding control show clear benefit.
• Timing Matters: Early use in acute bleeding scenarios yields better outcomes.
• Risk-Benefit: Individual assessment of clot risk is necessary.

Alternative Choices

Competing Drugs

What are the alternatives if TXA is not suitable?

Alternatives include aminocaproic acid (EACA) and local hemostatic measures such as topical agents, direct pressure, or surgical hemostasis.

Aprotinin is another antifibrinolytic but has limited availability and a different risk profile; choice depends on bleeding site and patient comorbidities.

For heavy menstrual bleeding, NSAIDs and hormonal therapies (combined or progestin-only methods) are commonly used as first-line alternatives or adjuncts.

When To Pick Alternatives

When should clinicians choose something other than tranexamic acid?

If you have absolute contraindications such as active thrombosis or seizure history, alternatives or non-pharmacologic hemostatic measures are preferred.

In significant renal impairment where dosing is complex, local measures or alternative systemic agents may be safer depending on the clinical scenario.

Regulation Snapshot

Prescription Status

Is tranexamic acid prescription-only?

Tranexamic acid is prescription-only (Rx) in the listed countries and not available over the counter in those markets.

The ATC code for tranexamic acid is B02AA02.

Global Brand/Regulatory Notes

What brands and regulatory bodies are associated with tranexamic acid globally?

Common brand names include Cyklokapron, Exacyl, Amchafibrin and Lysteda in the United States for oral use.

Regulatory agencies that list product data include ANMDMR (Romania), AEMPS (Spain), BfArM (Germany), ANSM (France), EOF (Greece), Health Canada, MHRA (UK), TGA (Australia) and national agencies across the EU.

Always fill prescriptions at licensed pharmacies and carry a copy of your prescription and medication leaflet when travelling because packaging and brand names differ internationally.

FAQ Section

Short Patient Q&A

Can I take Cyklokapron with birth control?

Tell your prescriber because combined hormonal contraception increases clot risk and needs clinician assessment before combining with tranexamic acid.

How quickly does it work for heavy periods?

Many patients notice reduced bleeding within one to two cycles, with symptomatic improvement often during the first treated period.

Can I drive after taking it?

Most people can drive, but do not drive if you feel dizzy or experience visual changes.

Quick Troubleshooting

What to do about common problems.

If you develop nausea, take tranexamic acid tablets with food or a snack unless advised otherwise by your clinician.

For missed doses, take the missed dose when you remember unless it is close to the next scheduled dose; do not double up doses.

If you get swelling, shortness of breath, severe headache, or vision changes, stop the medicine and seek emergency care.

Guidelines for Proper Use

Before You Start

What to check before beginning tranexamic acid.

Disclose any history of blood clots, seizures, kidney disease, and all current medications including hormonal contraceptives and anticoagulants.

Confirm the prescription details and the product form — common forms include 500 mg tablets and 100 mg/mL IV ampoules or vials.

Ask your clinician about renal dosing if you have impaired kidney function or are elderly with reduced renal clearance.

During Treatment & Follow-Up

How to manage treatment and what follow-up is required.

Follow the prescribed dose and duration carefully; menorrhagia regimens are typically limited to up to five days per cycle while perioperative regimens vary by protocol.

Store tablets below 25°C in a dry place and keep injections below 25°C while avoiding freezing and protecting from light during transport.

Monitor for side effects such as headache, GI upset, or visual disturbances and report any concerning signs to your clinician immediately.

Plan follow-up to reassess bleeding control and side effects; short courses commonly need only routine check-ins while longer or repeated courses should be overseen by a specialist.

• Pre-Start Checklist: disclose clots, seizures, renal disease, all meds; confirm formulation and dosing.
• Daily Medication Log Template: Date | Time | Dose | Notes (missed dose, nausea, other side effects).
• Follow-Up: schedule reassessment after first treated cycle or as directed by prescriber.

Delivery Across United States